MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
Summary: Advanced prostate cancers are treated with therapies targeting the androgen receptor (AR) signaling pathway. While many tumors initially respond to AR inhibition, nearly all develop resistance. It is critical to understand how prostate tumor cells respond to AR inhibition in order to exploi...
相似书籍
-
ZFP36-mediated mRNA decay regulates metabolism
由: Andrew C. Cicchetto, et al.
出版: (2023-05-01) -
Uptake of tumor-derived microparticles induces metabolic reprogramming of macrophages in the early metastatic lung
由: Kelly Kersten, et al.
出版: (2023-06-01) -
Endothelial Jagged1 levels and distribution are post-transcriptionally controlled by ZFP36 decay proteins
由: Hannah L. Sunshine, et al.
出版: (2024-01-01) -
AAV5-mediated manipulation of insulin expression in choroid plexus has long-term metabolic and behavioral consequences
由: Caio Henrique Mazucanti, et al.
出版: (2023-08-01) -
Comparative transcriptomic profiling reveals a role for Olig1 in promoting axon regeneration
由: Xiu-Qing Fu, et al.
出版: (2024-07-01)